8-K filing — INTELLIGENT BIO SOLUTIONS INC. (INBS)
Filed: 2026-09-11 AccNo: 0001493152-26-042411 Size: 197 KB Item 8.01: Other Events
Stocks · News reference
Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market
Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screening system to enter the US market.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UPDATE: Intelligent Bio Solutions Commences ~$5M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share
Intelligent Bio Solutions Inc. ("INBS" or the "Company") (NASDAQ:INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has entered
Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission To September 2026
Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the results of its